Carmen L. Isache, M.D. » Medicine ...

Dr. Carmen Isache, MD

Claim this profile

University of Florida-JAX-ASCENT

Studies COVID-19
Studies Coronavirus
6 reported clinical trials
12 drugs studied

Area of expertise

1COVID-19
Carmen Isache, MD has run 4 trials for COVID-19. Some of their research focus areas include:
SARS-CoV-2
2Coronavirus
Carmen Isache, MD has run 4 trials for Coronavirus. Some of their research focus areas include:
SARS-CoV-2
PCR
collection

Affiliated Hospitals

Image of trial facility.
University Of Florida-JAX-ASCENT
Image of trial facility.
University Of Florida College Of Medicine - Jacksonville

Clinical Trials Carmen Isache, MD is currently running

Image of trial facility.

Sleep Treatments

for Long COVID Syndrome

The platform protocol is designed to be flexible so that it is suitable for a range of study settings and intervention types. Therefore, the platform protocol provides a general protocol structure that can be shared by multiple interventions and allows comparative analysis across the interventions. For example, objectives, measures, and endpoints are generalized in the platform protocol, but intervention-specific features are detailed in separate appendices. This platform protocol is a prospective, multi-center, multi-arm, randomized controlled platform trial evaluating potential interventions for PASC-mediated sleep disturbances. The hypothesis is that symptoms of sleep and circadian disorders that emerge in patients with PASC can be improved by phenotype-targeted interventions. Specific sleep and circadian disorders addressed in this protocol include sleep-related daytime impairment (referred to as hypersomnia) and complex PASC-related sleep disturbance (reflecting symptoms of insomnia and sleep-wake rhythm disturbance).
Recruiting0 awards Phase 21 criteria
Image of trial facility.

Rehabilitation and Pacing

for Long COVID

This is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and treatment plans if results achieve key study outcomes. This protocol is a prospective, multi-center, multi-arm, randomized, controlled platform trial evaluating interventions to address and improve exercise intolerance and post-exertional malaise (PEM) as manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). The focus of this protocol is to assess interventions that can improve exercise capacity, daily activities tolerance, and quality of life in patients with PASC.
Recruiting1 award N/A2 criteria

More about Carmen Isache, MD

Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Carmen Isache, MD has experience with
  • Placebo
  • Montelukast
  • Fluticasone
  • Fluvoxamine
  • Ivermectin
  • Metformin

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Carmen Isache, MD specialize in?
Is Carmen Isache, MD currently recruiting for clinical trials?
Are there any treatments that Carmen Isache, MD has studied deeply?
What is the best way to schedule an appointment with Carmen Isache, MD?
What is the office address of Carmen Isache, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security